Biospecifics Technologies Corp (NASDAQ:BSTC)

42.70
BATS BZX Real-Time Price
As of 12:22pm ET
 -1.21 / -2.76%
Today’s Change
38.05
Today|||52-Week Range
53.77
-1.45%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$299.7M

Company Description

BioSpecifics Technologies Corp. engages in the development of an injectable collagenase for multiple indications. Its products include XIAFLEX, which is a treatment used for Dupuytren's contracture. The company was founded in 1990 and is headquartered in Lynbrook, NY.

Contact Information

Biospecifics Technologies Corp.
35 Wilbur Street
Lynbrook New York 11563
P:(516) 593-7000
Investor Relations:

Employees

Shareholders

Other institutional39.98%
Individual stakeholders36.73%
Mutual fund holders18.89%

Top Executives

Thomas L. WegmanPresident, CEO & Principal Financial Officer